Everand Logo

Welcome to Everand!

  • STAT

    Trump’s new tone with drug makers: gratitude

    by Ike Swetlitz and Lev Facher Aug 08, 2018 2 minutes
    President Trump listens to health secretary Alex Azar speak in the Rose Garden.

    WASHINGTON — The drug industry’s much-publicized pledges not to hike their prices — however temporary they might be — are clearly keeping President Trump happy.

    Tuesday, at a dinner at his New Jersey golf course, Trump didn’t accuse the industry of or lament “RIPOFF” prices, as he has

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A White House Drug-shortage Plan, A Genmab Deal, And More
    A White House plan to stem drug shortages involves basing Medicare payments on whether hospitals adopt business practices that avoid shortages.
    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
    BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.

    Related Books & Audiobooks